CXCL12 and neoplasm: Considering the association between the CXCL12-related risk score and immunosuppressive checkpoint molecules, we committed to explore the association between the risk score and response to immunotherapy, which worked mainly by blocking immunosuppressive checkpoint molecules and reactivating effector T cells to enhance anti-tumor immunity.